ID27275A - Intermediet dan proses untuk pembuatan olanzapin - Google Patents

Intermediet dan proses untuk pembuatan olanzapin

Info

Publication number
ID27275A
ID27275A IDW990058D ID990058D ID27275A ID 27275 A ID27275 A ID 27275A ID W990058 D IDW990058 D ID W990058D ID 990058 D ID990058 D ID 990058D ID 27275 A ID27275 A ID 27275A
Authority
ID
Indonesia
Prior art keywords
intermediet
olanzapin
making
making olanzapin
Prior art date
Application number
IDW990058D
Other languages
English (en)
Indonesian (id)
Inventor
Charles Arthur Bunnell
Samuel Dean Larsen
John Richard Nichols
Susan Marie Reutzel
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27275(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID27275A publication Critical patent/ID27275A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW990058D 1996-09-23 1997-09-18 Intermediet dan proses untuk pembuatan olanzapin ID27275A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
ID27275A true ID27275A (id) 2001-03-22

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990058D ID27275A (id) 1996-09-23 1997-09-18 Intermediet dan proses untuk pembuatan olanzapin

Country Status (35)

Country Link
US (1) US6020487A (enExample)
EP (1) EP0831098B1 (enExample)
JP (2) JP2001500877A (enExample)
KR (1) KR100560015B1 (enExample)
CN (1) CN1122036C (enExample)
AR (1) AR013838A1 (enExample)
AT (1) ATE209208T1 (enExample)
AU (1) AU719441B2 (enExample)
BR (1) BR9712100A (enExample)
CA (1) CA2265712C (enExample)
CO (1) CO4910140A1 (enExample)
CZ (1) CZ299248B6 (enExample)
DE (1) DE69708428T2 (enExample)
DK (1) DK0831098T3 (enExample)
EA (1) EA001642B1 (enExample)
EG (1) EG23861A (enExample)
ES (1) ES2166051T3 (enExample)
HU (1) HU226484B1 (enExample)
ID (1) ID27275A (enExample)
IL (1) IL128962A (enExample)
IN (1) IN187156B (enExample)
MY (1) MY125565A (enExample)
NO (1) NO323980B1 (enExample)
NZ (1) NZ334448A (enExample)
PE (1) PE110398A1 (enExample)
PL (3) PL196069B1 (enExample)
PT (1) PT831098E (enExample)
RS (1) RS49598B (enExample)
SI (1) SI0831098T1 (enExample)
SV (1) SV1997000081A (enExample)
TR (1) TR199900640T2 (enExample)
TW (1) TW470746B (enExample)
UA (1) UA59371C2 (enExample)
WO (1) WO1998012199A1 (enExample)
ZA (1) ZA978515B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2003566A3 (cs) * 2000-08-31 2004-01-14 Dr. Reddy's Laboratories Ltd. Způsob přípravy hydrátů olanzapinu a jejich konverze na krystalické formy olanzapinu
US6740753B2 (en) * 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
WO2003037903A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
CH695862A5 (fr) 2001-12-24 2006-09-29 Sun Pharmaceutical Ind Ltd Forme cristalline I de la methyl-4-(4-methyl-1-piperazinyl) 10H-thieno [2,3-b] [1,5] benzodiazepine.
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
WO2003101997A1 (en) 2002-05-31 2003-12-11 Geneva Pharmaceuticals, Inc. Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
AU2003300324A1 (en) * 2002-12-24 2004-07-22 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
CA2546200A1 (en) * 2003-11-18 2005-06-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
PL1611139T3 (pl) * 2003-12-22 2008-10-31 Teva Pharma Sposób wytwarzania olenzapiny
EP1709053B1 (en) 2004-01-27 2011-04-06 Synthon B.V. Stable salts of olanzapine
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
ES2289974T1 (es) * 2004-07-14 2008-02-16 Shasun Chemicals And Drugs Limited Metodo mejorado para producir la forma i de la olanzapina.
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006027800A1 (en) * 2004-09-06 2006-03-16 Shasun Chemicals And Drugs Limited A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine
KR101290115B1 (ko) * 2004-11-16 2013-07-29 엘커메스 파마 아일랜드 리미티드 주사가능한 나노입자형 올란자핀 제형
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンii型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
AU668159B2 (en) * 1992-05-29 1996-04-26 Lilly Industries Limited Pharmaceutical compounds
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
NZ334346A (en) * 1996-09-23 2000-05-26 Lilly Co Eli Olanzapine dihydrate D comprising 2-methyl-4-(4-methyl-1-piperazinyl)-1OH-thieno[2,3-b][1,5]benzodiazepine and a formulation for use in treating central nervous system disorders

Also Published As

Publication number Publication date
EA001642B1 (ru) 2001-06-25
CO4910140A1 (es) 2000-04-24
PL332482A1 (en) 1999-09-13
RS49598B (sr) 2007-06-04
CN1234802A (zh) 1999-11-10
AU4484197A (en) 1998-04-14
IN187156B (enExample) 2002-02-16
EA199900326A1 (ru) 1999-08-26
CA2265712C (en) 2006-10-31
EP0831098B1 (en) 2001-11-21
MY125565A (en) 2006-08-30
TW470746B (en) 2002-01-01
SV1997000081A (es) 1999-01-14
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
PE110398A1 (es) 1999-01-14
DK0831098T3 (da) 2002-05-21
SI0831098T1 (en) 2002-04-30
PL194565B1 (pl) 2007-06-29
HUP0000066A3 (en) 2000-11-28
IL128962A0 (en) 2000-02-17
DE69708428D1 (de) 2002-01-03
PL196068B1 (pl) 2007-12-31
CA2265712A1 (en) 1998-03-26
ES2166051T3 (es) 2002-04-01
TR199900640T2 (xx) 1999-06-21
NO991382D0 (no) 1999-03-22
AU719441B2 (en) 2000-05-11
AR013838A1 (es) 2001-01-31
HK1009807A1 (en) 1999-06-11
CN1122036C (zh) 2003-09-24
HUP0000066A2 (hu) 2000-06-28
HU226484B1 (en) 2009-03-02
JP2001500877A (ja) 2001-01-23
DE69708428T2 (de) 2002-07-04
CZ99099A3 (cs) 1999-11-17
UA59371C2 (uk) 2003-09-15
US6020487A (en) 2000-02-01
IL128962A (en) 2003-01-12
PL196069B1 (pl) 2007-12-31
EP0831098A3 (en) 1998-04-29
BR9712100A (pt) 1999-08-31
EG23861A (en) 2007-11-18
ATE209208T1 (de) 2001-12-15
ZA978515B (en) 1999-03-23
EP0831098A2 (en) 1998-03-25
KR20000048520A (ko) 2000-07-25
KR100560015B1 (ko) 2006-03-15
NO323980B1 (no) 2007-07-30
YU15599A (sh) 2001-12-26
NO991382L (no) 1999-03-22
JP2009242407A (ja) 2009-10-22
PT831098E (pt) 2002-04-29
CZ299248B6 (cs) 2008-05-28

Similar Documents

Publication Publication Date Title
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
ID16930A (id) Peralatan fotovoltaik dan proses untuk produksinya
ID28728A (id) Komposisi dan proses pengkrepan
ID18494A (id) Turunan pirazola leburan dan proses pembuatannya
ID15947A (id) Senyawa fenol dan proses pembuatannya
ID17271A (id) Proses untuk pengubahan etilbenzena
ID17307A (id) Komposisi oral dan proses pembuatannya.
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
ID27275A (id) Intermediet dan proses untuk pembuatan olanzapin
ID30506A (id) Proses pengembangan ko-produksi 6-aminokapronitril dan heksametilenadiamino
ID26902A (id) Proses dan radas untuk pembuatan melamina
ID15992A (id) Papan lamina dan proses pembuatannya
ID16282A (id) Lensa intraokuler dan proses untuk pembuatannya
ID16923A (id) Komposisi-komposisi bitumen dan proses pembuatannya
ID18521A (id) Proses asetoksilasi olefin-olefin
ID18026A (id) Proses polimerisasi
ID19384A (id) Proses polimerisasi
ID16994A (id) Unit proses
ID15861A (id) Instalasi dan proses metalurgi mengandung fero
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID26660A (id) Proses pembuatan butana-1,4-diol, gamma-butirolakton dan tetrahidrofuran
ID16410A (id) Proses produksi lipstatin dan tetrahidrolipstatin
ID16617A (id) Proses penggilingan basah dan penggiling untuk melakukan proses tersebut
ID16858A (id) PROSES PEMBUATAN TERPOLIMER ETILENA SUATU-alpha-OLEFIN DAN DIENA.
ID15862A (id) Proses